Table 1.
Means ± standard deviations of background variables, and percentages of current medication use.
| ASD | BD | TD | |
|---|---|---|---|
| n | 38 | 12 | 13 |
| Age | 10.16 ± 1.92 | 10.08 ± 1.31 | 10.77 ± 1.48 |
| SES | 53.72 ± 10.39 | 50.92 ± 11.83 | 53.58 ± 9.15 |
| ICV (cm3) | 1294.99 ± 103.08 | 1267.37 ± 77.16 | 1274.10 ± 114.48 |
| FSIQ | 99.37 ± 16.08d (73-127)a |
102.17 ± 12.16e (86-126) |
115.15 ± 9.41 (93-133) |
| VIQ | 104.55 ± 18.04d | 101.17 ± 12.48d | 118.77 ±12.34 |
| PIQ | 94.42 ± 16.85d | 103.41 ±14.43 | 108.54 ± 9.54 |
| ADHDa | 47% | 75% | - |
| Medications | |||
| Total Medicatedc | 20 (54%) | 8 (73%) | |
| Stimulant | 11 (30%) | 2 (18%) | - |
| Neuroleptic | 5 (14%) | 6 (55%) | - |
| SSRI | 10 (27%) | 3 (27%) | - |
| Mood Stabilizer | 3 (8%) | 6 (55%) | - |
SES = socioeconomic status, ICV = intracranial volume, FSIQ = full scale IQ, VIQ = verbal IQ, PIQ = performance IQ, ADHD = Attention Deficit Hyperactivity Disorder, SSRI = selective serotonin reuptake inhibitor.
a
range of FSIQ scores
b
ADHD diagnosis was determined based on parental reports from the K-SADS-IVR, and included all subtypes (inattentive, hyperactive and combination).
c
The number and percent of individuals in each group being medicated with any drug during the study
d
No significant differences were noted between the ASD and BD groups. Compared to the TD group, however, several significant differences were observed: p <.05 &
e
p <.01.